Dr. May Griffith is a Professor in the Department of Ophthalmology and a member of the Institute of Biomedical Engineering at the Université de Montréal. MG earned her Ph.D. from the University of Toronto and completed postdoctoral research in developmental cell biology at the University of Alberta and Harvard Medical School in Boston, USA. MG also has a Master's degree in Business Administration, which allows her to combine her business and science backgrounds. She has consulted on technology transfer, research and development planning, and start-up assistance with various private and government organizations.
      MG holds the Canada Research Chair in Biomaterials and Stem Cells in Ophthalmology, the Caroline Durand Foundation Research Chair in Cellular Therapy of the Eye, and is Director of the Cornea and Anterior Segment Axis of the Quebec Vision Health Research Network.
      MG is known for her pioneering work in translational regenerative medicine and in situ tissue regeneration. She led an international, multidisciplinary team developing the world's first cell-free biosynthetic corneal implants that promoted human corneal tissue and nerve regeneration. Since then, she and her team have completed a second clinical trial with biosynthetic corneal implants containing an inflammation-suppressing polymer network on high-risk patients. In addition, MG continues her bench-to-bedside work in cornea regeneration, most recently working on a fully synthetic, biomimetic injectable Liquid Cornea to address transplantation needs in remote regions in Canada and globally to meet unmet medical needs in corneal blindness treatment.